Furthermore, the oncogenic transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) has emerged as a pivotal contributor to NSCLC development. The gene discussed is NFKB1; the disease is non-small cell lung carcinoma.